{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:20:21Z","timestamp":1762917621705},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR10872\/NNT\/28\/135\/2008"],"award-info":[{"award-number":["BT\/PR10872\/NNT\/28\/135\/2008"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ejps.2015.10.023","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T21:04:27Z","timestamp":1446584667000},"page":"11-20","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Improved protection against tuberculosis after boosting the BCG-primed mice with subunit Ag 85a delivered through intact skin with deformable vesicles"],"prefix":"10.1016","volume":"82","author":[{"given":"Gavish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh Datta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Cevc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amla","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.10.023_bb0005","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/IAI.59.4.1558-1563.1991","article-title":"T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis","volume":"59","author":"Andersen","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2015.10.023_bb0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"Bal","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.10.023_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0009-3084(93)90064-A","article-title":"Electrostatic characterization of liposomes","volume":"64","author":"Cevc","year":"1993","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2015.10.023_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v13.i3-4.30","article-title":"Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery","volume":"13","author":"Cevc","year":"1996","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2015.10.023_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","article-title":"Lipid vesicles and other colloids as drug carriers on the skin","volume":"56","author":"Cevc","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2015.10.023_bb0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2012.01.005","article-title":"Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy","volume":"160","author":"Cevc","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0006-3495(03)74917-0","article-title":"Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier","volume":"84","author":"Cevc","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2015.10.023_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejps.2014.01.006","article-title":"Non-invasive, epicutaneous immunisation with toxoid in deformable vesicles protects mice against tetanus, chiefly owing to a Th2 response","volume":"56","author":"Chopra","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.10.023_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023360","article-title":"A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis","volume":"6","author":"Dey","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2015.10.023_bb0050","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s11095-011-0448-z","article-title":"Turbidity spectroscopy for characterization of submicroscopic drug carriers, such as nanoparticles and lipid vesicles: size determination","volume":"28","author":"Elsayed","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.10.023_bb0055","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2015.10.023_bb0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin","volume":"391","author":"Glenn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2015.10.023_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.qco.0000168380.08895.9a","article-title":"Recent developments in tuberculosis vaccines","volume":"18","author":"Haile","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejps.2015.10.023_bb0070","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-3083.2008.02133.x","article-title":"Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis","volume":"68","author":"Kumar","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2015.10.023_bb0085","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2015.10.023_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2012.07.016","article-title":"Devices for overcoming biological barriers: the use of physical forces to disrupt the barriers","volume":"65","author":"Mitragotri","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2015.10.023_bb0100","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2172-14-S1-S5","article-title":"Immunogenicity of recombinant Mycobacterium bovis bacille Calmette\u2013Gu\u00e8rin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens","volume":"14","author":"Mohamud","year":"2013","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"year":"2013","series-title":"Global tuberculosis report 2013","author":"Organization","key":"10.1016\/j.ejps.2015.10.023_bb0110"},{"key":"10.1016\/j.ejps.2015.10.023_bb0115","first-page":"145","article-title":"Noninvasive administration of protein antigens: transdermal immunization with bovine serum albumin in transfersomes","volume":"4","author":"Paul","year":"1995","journal-title":"Vaccine Res."},{"key":"10.1016\/j.ejps.2015.10.023_bb0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(97)00185-0","article-title":"Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes","volume":"16","author":"Paul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0125","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/S0264-410X(00)00432-1","article-title":"Liposome-mediated DNA vaccination: the effect of vesicle composition","volume":"19","author":"Perrie","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0130","first-page":"2565","article-title":"Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG","volume":"23","author":"Rodriguez","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1998.02166.x","article-title":"Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes)","volume":"138","author":"Schatzlein","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0140","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.4049\/jimmunol.176.8.4573","article-title":"Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine","volume":"176","author":"Schuurhuis","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"Scriba","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2015.10.023_bb0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejps.2005.07.002","article-title":"Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80","volume":"26","author":"Simoes","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.10.023_bb0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.10.023_bb0160","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/eji.200425196","article-title":"Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response","volume":"34","author":"Strid","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejps.2015.10.023_bb0165","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2015.10.023_bb0170","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0175","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/10611860802230158","article-title":"Adaptability and elasticity of the mixed lipid bilayer vesicles containing non-ionic surfactant designed for targeted drug delivery across the skin","volume":"16","author":"Wachter","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2015.10.023_bb0180","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2013.05.048","article-title":"Cutaneous vaccination: antigen delivery into or onto the skin","volume":"31","author":"Weniger","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2015.10.023_bb0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/MMBR.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871530052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871530052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T21:35:18Z","timestamp":1599773718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871530052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":37,"alternative-id":["S092809871530052X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.10.023","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved protection against tuberculosis after boosting the BCG-primed mice with subunit Ag 85a delivered through intact skin with deformable vesicles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}